The incidence of gastroenteropancreatic neuroendocrine tumors is on the rise. Cleveland Clinic’s growing program will be a hub for patients and providers, led by Michelle Kang Kim, MD, PhD, one of the only U.S. gastroenterologists specializing in neuroendocrine tumors.